<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01507987</url>
  </required_header>
  <id_info>
    <org_study_id>60039775/K</org_study_id>
    <secondary_id>CRD-619</secondary_id>
    <nct_id>NCT01507987</nct_id>
  </id_info>
  <brief_title>St.Jude Medical Cardiac Lead Assessment Study</brief_title>
  <acronym>CLAS</acronym>
  <official_title>St.Jude Medical Cardiac Lead Assessment Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Cardiac Lead Assessment Study (CLAS) is designed as a prospective, non-randomized,&#xD;
      multi-center, international postmarket surveillance study under 522 Order PS120111 (August&#xD;
      16, 2012).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study was to determine the prevalence and incidence of externalized&#xD;
      conductors and other visual lead anomalies (as evidenced by imaging) and the risk of&#xD;
      progression to electrical dysfunction in subjects with one or more of the following St. Jude&#xD;
      Medical (SJM) cardiac leads: Riata leads, Riata ST leads, Durata and/or QuickSite/QuickFlex&#xD;
      Cardiac Resynchronization Therapy (CRT) leads.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2013</start_date>
  <completion_date type="Actual">September 2019</completion_date>
  <primary_completion_date type="Actual">June 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Leads With Electrical Dysfunction</measure>
    <time_frame>This outcome is assessed at enrollment and over the course of 3 years of follow-up</time_frame>
    <description>The prevalence of electrical dysfunction was calculated as the number of leads that have electrical dysfunction through three years of follow-up for the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Leads With Externalized Conductors</measure>
    <time_frame>This outcome is assessed at enrollment</time_frame>
    <description>The prevalence of externalized conductors was calculated as the number of leads that have been shown to have externalized conductors by imaging at the time of enrollment in each of the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Other Visual Lead Anomalies by Each Subcategory (Fracture, Kink, Subclavian Crush, Other Irregularities)</measure>
    <time_frame>This outcome is assessed at enrollment</time_frame>
    <description>The prevalence of other visual lead anomalies (by each subcategory) was calculated as the number of leads that have been shown to have other visual anomaly (by each subcategory) at the time of enrollment in each of the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Annual Hazard Rate of Lead Electrical Dysfunction in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</measure>
    <time_frame>This outcome is assessed from enrollment through the course of 3 years of follow-up</time_frame>
    <description>Annual hazard rate is the proportion of number of leads with electrical dysfunction to the total number of lead follow-up years.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Annual Hazard Rate of New Cases of Externalized Conductors (From Enrollment to Year 1) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</measure>
    <time_frame>year 1 follow-up</time_frame>
    <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from enrollment to year 1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Annual Hazard Rate of New Cases of Externalized Conductors (From Year 1 to Year 2) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</measure>
    <time_frame>year 1 to year 2 follow-up</time_frame>
    <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from year 1 to year 2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Annual Hazard Rate of New Cases of Externalized Conductors (From Year 2 to Year 3) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</measure>
    <time_frame>year 2 to year 3 follow-up</time_frame>
    <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from year 2 to year 3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Enrollment to Year 1) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</measure>
    <time_frame>This outcome is assessed from enrollment to year 1</time_frame>
    <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from enrollment to year 1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Year 1 to Year 2) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</measure>
    <time_frame>This outcome is assessed from year 1 to year 2 of follow-up</time_frame>
    <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from year 1 to year 2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Year 2 to Year 3) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</measure>
    <time_frame>This outcome is assessed from year 2 to year 3 follow-up</time_frame>
    <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from year 2 to year 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Externalized Conductors to Electrical Dysfunction, by Year of Initial Implant</measure>
    <time_frame>This outcome is assessed from time of detecting EC till the course of 3 years of follow-up</time_frame>
    <description>Kaplan-Meier analysis of time from externalized conductors (EC) to electrical dysfunction, by year of initial implant. Count of cumulative lead anomaly events from time of detecting EC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Other Visual Lead Anomaly to Electrical Dysfunction, by Year of Initial Implant</measure>
    <time_frame>This outcome is assessed from time of detecting other visual lead anomaly till the course of 3 years of follow-up</time_frame>
    <description>Kaplan-Meier analysis of time from other visual lead anomaly to electrical dysfunction, by year of initial implant. Count of cumulative lead anomaly events from time of detecting other visual lead anomaly</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With an Adverse Event Through 30 Days Post-intervention for Lead (e.g. Extraction, Abandonment, Revision, Other).</measure>
    <time_frame>within 30 days associated with study lead related interventions</time_frame>
    <description>Number of participants with adverse events within 30 days associated with study lead related interventions for each lead group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Externalized Conductors to Clinical Intervention, by Year of Initial Implant</measure>
    <time_frame>This outcome is assessed from time of detection of externalized conductor to 3 years follow-up</time_frame>
    <description>time from externalized conductors to clinical intervention for all lead subgroups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimation of Lead Anomaly Events From Time of Other Visual Lead Anomalies by Each Subcategory to Clinical Intervention, by Year of Initial Implant</measure>
    <time_frame>This outcome is assessed from time of detection of other visual lead anomaly until 3 years of follow-up</time_frame>
    <description>Kaplan-Meier analysis of time from visual lead anomalies for all lead and lead age subcategories to clinical intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Number of Patients With Externalized Conductors to Number of Patients Without Externalized Conductors (EC)</measure>
    <time_frame>This outcome is assessed from enrollment till the course of 3 years of follow-up</time_frame>
    <description>Comparison of patients with EC to those without EC: lead size effect on number of patients with or without EC (7F and 8F are lead sizes, F = French). Riata leads have 8F diameter and Riata ST leads have 7F diameter. The Riata/Riata ST families of leads were used for this comparison only to determine whether the difference in lead size (with the silicon material and other lead design factors controlled for) had an effect on externalization of conductors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Patients With Electrical Dysfunction to Those Without Electrical Dysfunction (ED).</measure>
    <time_frame>This outcome is assessed from enrollment till the course of 3 years of follow-up</time_frame>
    <description>Comparison of patients with ED to those without ED: subject age effect on ED</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2216</enrollment>
  <condition>Externalized Conductors</condition>
  <condition>Visual Lead Anomalies</condition>
  <condition>Electrical Dysfunction</condition>
  <arm_group>
    <arm_group_label>Patients with SJM leads implanted</arm_group_label>
    <description>Patient has at least one market released Riata, Riata ST, QuickSite/QuickFlex, or Durata lead implanted</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads</intervention_name>
    <description>Riata leads implanted between 2002-2009 Riata ST leads implanted between 2006-2009 Quicksite or QuickFlex leads implanted between 2006-2010 Durata leads implanted between 2008-2010&#xD;
Subjects were followed for three years and cinefluoroscopy imaging was done annually to determine prevalence of externalized conductors or other visual lead anomalies</description>
    <arm_group_label>Patients with SJM leads implanted</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that have a market released St. Jude Medical Implantable Cardioverter&#xD;
        Defibrillator (ICD) or Cardiac Resynchronization Therapy - Defibrillator (CRT-D) already&#xD;
        implanted and also have at least one market released Riata/ Riata&#xD;
        ST/QuickSite/QuickFlex/Durata already implanted.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient has a market released SJM Implantable Cardioverter Defibrillator (ICD), CRT-D&#xD;
             or CRT-P already implanted.&#xD;
&#xD;
          2. Patient has at least one market released Riata/ Riata ST/QuickSite/QuickFlex/Durata&#xD;
             already implanted in which the lead model number and lead implant date is indicated in&#xD;
             Table 1 (see protocol attached.)&#xD;
&#xD;
          3. Have the ability to provide informed consent for study participation and be willing to&#xD;
             comply with the prescribed evaluations as detailed in this study plan.&#xD;
&#xD;
          4. Are 18 years or above&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient is currently pregnant.&#xD;
&#xD;
          2. Enrolled or intend to participate in a clinical drug and/or device study, which could&#xD;
             confound the results of this trial as determined by SJM, during the course of this&#xD;
             clinical study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiology, P.C.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Center Research</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Arrhythmia Consultants</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Heart Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Green Hospital</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Rhythm Specialists</name>
      <address>
        <city>Reseda</city>
        <state>California</state>
        <zip>91335</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Group</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Medical Center</name>
      <address>
        <city>Stockton</city>
        <state>California</state>
        <zip>95204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penrose St. Francis Health Services</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80907</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naples Heart Rhytm Specialists, PA</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Redmond Regional Medical Center</name>
      <address>
        <city>Rome</city>
        <state>Georgia</state>
        <zip>30165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>OSF Healthcare Cardiovascular Institute</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mid-America Cardiology Associates, PC</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Clinic of Hammond, LLC</name>
      <address>
        <city>Hammond</city>
        <state>Louisiana</state>
        <zip>70403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sparrow Clinical Research Institute</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jackson Heart Clinic</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of North Mississippi</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Physicians Clinic-Heart Consultants</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deborah Heart and Lung</name>
      <address>
        <city>Browns Mills</city>
        <state>New Jersey</state>
        <zip>08015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico Heart Institute</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asheville Cardiology Associates</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Heart &amp; Vascular Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Consultants in Cardiovascular Diseases</name>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drexel University College oF Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donald Guthrie Foundation for Education and Research</name>
      <address>
        <city>Sayre</city>
        <state>Pennsylvania</state>
        <zip>18840</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellspan Health</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sutherland Cardiology Clinic</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mountain States Medical Group Cardiology</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arrhythmia Consultants</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Texas Cardiovascular Consultants</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora Medical Group</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>QE II Health Sciences</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Tsukuba Hospital</name>
      <address>
        <city>Tsukuba</city>
        <state>Ibaraki</state>
        <zip>305-8576</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka City University Hospital</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka</state>
        <zip>545-8565</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyoto-Katsura Hospital</name>
      <address>
        <city>Kyoto</city>
        <zip>615 8256</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Japan</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 6, 2012</study_first_submitted>
  <study_first_submitted_qc>January 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2012</study_first_posted>
  <results_first_submitted>January 21, 2021</results_first_submitted>
  <results_first_submitted_qc>July 29, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 23, 2021</results_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Externalized Conductors, visual lead an</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 18, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/87/NCT01507987/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study enrolled a total of 2,216 subjects at 45 sites to achieve an evaluable sample size of at least 1,401 subjects. The first subject enrolled in this study on March 20, 2013 and enrollment was completed in June, 2016 with the last follow-up completed in June 13 2019.</recruitment_details>
      <pre_assignment_details>A subject that has at least one market released lead implanted was eligible for enrollment in the study. Subjects could have more than one study lead implanted. Each lead group was considered separately for independent analyses.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Durata Leads</title>
          <description>Durata leads implanted between 2008-2010</description>
        </group>
        <group group_id="P2">
          <title>Riata Leads</title>
          <description>Riata leads implanted between 2002-2009</description>
        </group>
        <group group_id="P3">
          <title>Riata ST</title>
          <description>Riata ST leads implanted 2006-2009</description>
        </group>
        <group group_id="P4">
          <title>QuickSite/QuickFlex</title>
          <description>QuickSite/QuickFlex implanted 2006-2010</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="982"/>
                <participants group_id="P2" count="670"/>
                <participants group_id="P3" count="458"/>
                <participants group_id="P4" count="737"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="618"/>
                <participants group_id="P2" count="335"/>
                <participants group_id="P3" count="252"/>
                <participants group_id="P4" count="480"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="364"/>
                <participants group_id="P2" count="335"/>
                <participants group_id="P3" count="206"/>
                <participants group_id="P4" count="257"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The study enrolled a total of 2,216 study participants</population>
      <group_list>
        <group group_id="B1">
          <title>All Subjects Enrolled in the Study</title>
          <description>Demographics for all enrolled patients (N=2216)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2216"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="600"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1616"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2158"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="335"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1770"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2085"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Japan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Leads With Electrical Dysfunction</title>
        <description>The prevalence of electrical dysfunction was calculated as the number of leads that have electrical dysfunction through three years of follow-up for the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups.</description>
        <time_frame>This outcome is assessed at enrollment and over the course of 3 years of follow-up</time_frame>
        <population>All SJM leads enrolled in the study with Durata, Riata, Riata ST, or QuickSite/QuickFlex leads</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Leads With Electrical Dysfunction</title>
          <description>The prevalence of electrical dysfunction was calculated as the number of leads that have electrical dysfunction through three years of follow-up for the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups.</description>
          <population>All SJM leads enrolled in the study with Durata, Riata, Riata ST, or QuickSite/QuickFlex leads</population>
          <units>implanted leads</units>
          <param>Count of Units</param>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="982"/>
                <count group_id="O2" value="670"/>
                <count group_id="O3" value="458"/>
                <count group_id="O4" value="737"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="982"/>
                <count group_id="O2" value="670"/>
                <count group_id="O3" value="458"/>
                <count group_id="O4" value="737"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Leads With Externalized Conductors</title>
        <description>The prevalence of externalized conductors was calculated as the number of leads that have been shown to have externalized conductors by imaging at the time of enrollment in each of the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups</description>
        <time_frame>This outcome is assessed at enrollment</time_frame>
        <population>All SJM leads enrolled in the study with Durata, Riata, Riata ST, or QuickSite/QuickFlex leads</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Leads With Externalized Conductors</title>
          <description>The prevalence of externalized conductors was calculated as the number of leads that have been shown to have externalized conductors by imaging at the time of enrollment in each of the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups</description>
          <population>All SJM leads enrolled in the study with Durata, Riata, Riata ST, or QuickSite/QuickFlex leads</population>
          <units>implanted leads</units>
          <param>Count of Units</param>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="973"/>
                <count group_id="O2" value="660"/>
                <count group_id="O3" value="452"/>
                <count group_id="O4" value="723"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="973"/>
                <count group_id="O2" value="660"/>
                <count group_id="O3" value="452"/>
                <count group_id="O4" value="723"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="144"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Other Visual Lead Anomalies by Each Subcategory (Fracture, Kink, Subclavian Crush, Other Irregularities)</title>
        <description>The prevalence of other visual lead anomalies (by each subcategory) was calculated as the number of leads that have been shown to have other visual anomaly (by each subcategory) at the time of enrollment in each of the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups.</description>
        <time_frame>This outcome is assessed at enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Other Visual Lead Anomalies by Each Subcategory (Fracture, Kink, Subclavian Crush, Other Irregularities)</title>
          <description>The prevalence of other visual lead anomalies (by each subcategory) was calculated as the number of leads that have been shown to have other visual anomaly (by each subcategory) at the time of enrollment in each of the 4 lead groups divided by total number of leads in enrolled patients in each of the 4 lead groups.</description>
          <units>implanted leads</units>
          <param>Count of Units</param>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="974"/>
                <count group_id="O2" value="646"/>
                <count group_id="O3" value="454"/>
                <count group_id="O4" value="724"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="974"/>
                <count group_id="O2" value="646"/>
                <count group_id="O3" value="454"/>
                <count group_id="O4" value="724"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Annual Hazard Rate of Lead Electrical Dysfunction in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</title>
        <description>Annual hazard rate is the proportion of number of leads with electrical dysfunction to the total number of lead follow-up years.</description>
        <time_frame>This outcome is assessed from enrollment through the course of 3 years of follow-up</time_frame>
        <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>The Annual Hazard Rate of Lead Electrical Dysfunction in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</title>
          <description>Annual hazard rate is the proportion of number of leads with electrical dysfunction to the total number of lead follow-up years.</description>
          <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
          <units>leads with electrical dysfunction/years</units>
          <param>Number</param>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="982"/>
                <count group_id="O2" value="670"/>
                <count group_id="O3" value="458"/>
                <count group_id="O4" value="737"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="982"/>
                <count group_id="O2" value="670"/>
                <count group_id="O3" value="458"/>
                <count group_id="O4" value="737"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.010"/>
                    <measurement group_id="O2" value="0.019"/>
                    <measurement group_id="O3" value="0.014"/>
                    <measurement group_id="O4" value="0.001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Annual Hazard Rate of New Cases of Externalized Conductors (From Enrollment to Year 1) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</title>
        <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from enrollment to year 1</description>
        <time_frame>year 1 follow-up</time_frame>
        <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>The Annual Hazard Rate of New Cases of Externalized Conductors (From Enrollment to Year 1) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</title>
          <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from enrollment to year 1</description>
          <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
          <units>leads with externalized conductors/years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="808"/>
                <count group_id="O2" value="375"/>
                <count group_id="O3" value="316"/>
                <count group_id="O4" value="556"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="808"/>
                <count group_id="O2" value="375"/>
                <count group_id="O3" value="316"/>
                <count group_id="O4" value="556"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0025" lower_limit="0.0003" upper_limit="0.0089"/>
                    <measurement group_id="O2" value="0.0480" lower_limit=".0287" upper_limit="0.0748"/>
                    <measurement group_id="O3" value="0.0158" lower_limit="0.0052" upper_limit="0.0365"/>
                    <measurement group_id="O4" value="0.0288" lower_limit="0.0165" upper_limit="0.0463"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Annual Hazard Rate of New Cases of Externalized Conductors (From Year 1 to Year 2) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</title>
        <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from year 1 to year 2</description>
        <time_frame>year 1 to year 2 follow-up</time_frame>
        <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>The Annual Hazard Rate of New Cases of Externalized Conductors (From Year 1 to Year 2) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</title>
          <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from year 1 to year 2</description>
          <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
          <units>leads with externalized conductors/years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="687"/>
                <count group_id="O2" value="301"/>
                <count group_id="O3" value="256"/>
                <count group_id="O4" value="462"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="687"/>
                <count group_id="O2" value="301"/>
                <count group_id="O3" value="256"/>
                <count group_id="O4" value="462"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0015" lower_limit="0" upper_limit="0.0081"/>
                    <measurement group_id="O2" value="0.0897" lower_limit="0.0599" upper_limit="0.1278"/>
                    <measurement group_id="O3" value="0.0234" lower_limit="0.0086" upper_limit="0.0503"/>
                    <measurement group_id="O4" value="0.0087" lower_limit="0.0024" upper_limit="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Annual Hazard Rate of New Cases of Externalized Conductors (From Year 2 to Year 3) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</title>
        <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from year 2 to year 3</description>
        <time_frame>year 2 to year 3 follow-up</time_frame>
        <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>The Annual Hazard Rate of New Cases of Externalized Conductors (From Year 2 to Year 3) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads.</title>
          <description>Annual hazard rate calculated as ratio of all leads that are adjudicated by the committee and a have definite outcome of presence of externalized conductors to total follow-up years from year 2 to year 3</description>
          <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
          <units>leads with externalized conductors/years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="570"/>
                <count group_id="O2" value="228"/>
                <count group_id="O3" value="206"/>
                <count group_id="O4" value="362"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="570"/>
                <count group_id="O2" value="228"/>
                <count group_id="O3" value="206"/>
                <count group_id="O4" value="362"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0035" lower_limit="0.0004" upper_limit="0.0126"/>
                    <measurement group_id="O2" value="0.0658" lower_limit="0.0373" upper_limit="0.1062"/>
                    <measurement group_id="O3" value="0.0097" lower_limit="0.0012" upper_limit="0.0346"/>
                    <measurement group_id="O4" value="0.0110" lower_limit="0.003" upper_limit="0.0280"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Enrollment to Year 1) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</title>
        <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from enrollment to year 1</description>
        <time_frame>This outcome is assessed from enrollment to year 1</time_frame>
        <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Enrollment to Year 1) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</title>
          <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from enrollment to year 1</description>
          <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
          <units>leads w other visual lead anomaly/years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="803"/>
                <count group_id="O2" value="461"/>
                <count group_id="O3" value="343"/>
                <count group_id="O4" value="571"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="803"/>
                <count group_id="O2" value="461"/>
                <count group_id="O3" value="343"/>
                <count group_id="O4" value="571"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0025" lower_limit="0.0003" upper_limit="0.0090"/>
                    <measurement group_id="O2" value="0.0108" lower_limit="0.0035" upper_limit="0.0251"/>
                    <measurement group_id="O3" value="0.0117" lower_limit="0.0032" upper_limit="0.0296"/>
                    <measurement group_id="O4" value="0.0053" lower_limit="0.0011" upper_limit="0.0153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Year 1 to Year 2) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</title>
        <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from year 1 to year 2</description>
        <time_frame>This outcome is assessed from year 1 to year 2 of follow-up</time_frame>
        <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Year 1 to Year 2) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</title>
          <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from year 1 to year 2</description>
          <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
          <units>leads w other visual lead anomaly/years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="254"/>
                <count group_id="O2" value="374"/>
                <count group_id="O3" value="286"/>
                <count group_id="O4" value="482"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="254"/>
                <count group_id="O2" value="374"/>
                <count group_id="O3" value="286"/>
                <count group_id="O4" value="482"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0.0054"/>
                    <measurement group_id="O2" value="0.0027" lower_limit="0.0001" upper_limit="0.0148"/>
                    <measurement group_id="O3" value="0.0070" lower_limit="0.0008" upper_limit="0.025"/>
                    <measurement group_id="O4" value="0.0021" lower_limit="0.0001" upper_limit="0.0115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Year 2 to Year 3) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</title>
        <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from year 2 to year 3</description>
        <time_frame>This outcome is assessed from year 2 to year 3 follow-up</time_frame>
        <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST</title>
            <description>Riata ST leads implanted 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex</title>
            <description>QuickSite/QuickFlex implanted 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>The Annual Hazard Rate of New Cases of Other Visual Lead Anomalies by Each Subcategory (From Year 2 to Year 3) in the Riata, Riata ST, QuickSite/QuickFlex (1056T, 1058T, 1156T, 1158T) and Durata Leads</title>
          <description>Annual hazard rate calculated as proportion of leads adjudicated by the committee and a have definite outcome of presence of other visual lead anomaly to total follow up years from year 2 to year 3</description>
          <population>The annual hazard rate was assessed separately in each of the 4 lead groups.</population>
          <units>leads w other visual lead anomaly/years</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>implanted leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="565"/>
                <count group_id="O2" value="305"/>
                <count group_id="O3" value="229"/>
                <count group_id="O4" value="387"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implanted leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="565"/>
                <count group_id="O2" value="305"/>
                <count group_id="O3" value="229"/>
                <count group_id="O4" value="387"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0.0065"/>
                    <measurement group_id="O2" value="0.0066" lower_limit="0.0008" upper_limit="0.0235"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="0.0160"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="0.0095"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Externalized Conductors to Electrical Dysfunction, by Year of Initial Implant</title>
        <description>Kaplan-Meier analysis of time from externalized conductors (EC) to electrical dysfunction, by year of initial implant. Count of cumulative lead anomaly events from time of detecting EC</description>
        <time_frame>This outcome is assessed from time of detecting EC till the course of 3 years of follow-up</time_frame>
        <population>N at risk from detecting externalized conductors at each follow-up time point</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads Lead Age: Less Than 4 Years</title>
            <description>lead age: less than 4 years</description>
          </group>
          <group group_id="O2">
            <title>Durata Leads Lead Age: 4 to Less Than 5 Years</title>
            <description>lead age: 4 to less than 5 years</description>
          </group>
          <group group_id="O3">
            <title>Durata Leads Lead Age: 5 Years or Greater</title>
            <description>lead age: 5 years or greater</description>
          </group>
          <group group_id="O4">
            <title>Riata Leads Lead Age: Less Than 6 Years</title>
            <description>lead age: less than 6 years</description>
          </group>
          <group group_id="O5">
            <title>Riata Leads Lead Age: 6-less Than 7 Years</title>
            <description>lead age: 6-less than 7 years</description>
          </group>
          <group group_id="O6">
            <title>Riata Leads Lead Age: 7 Years or Greater</title>
            <description>lead age: 7 years or greater</description>
          </group>
          <group group_id="O7">
            <title>Riata ST Lead Age: Less Than 5.5 Years</title>
            <description>lead age: less than 5.5 years</description>
          </group>
          <group group_id="O8">
            <title>Riata ST Leads Lead Age: Greater Than or Equal to 5.5 Years</title>
            <description>lead age: greater than or equal to 5.5 years</description>
          </group>
          <group group_id="O9">
            <title>QuickSite/QuickFlex Lead Age: Less Than 5 Years</title>
            <description>lead age: less than 5 years</description>
          </group>
          <group group_id="O10">
            <title>QuickSite/QuickFlex Leads Lead Age: 5 to Less Than 6 Years</title>
            <description>lead age: 5 to less than 6 years</description>
          </group>
          <group group_id="O11">
            <title>QuickSite/QuickFlex Leads Lead Age: Greater Than or Equal to 6 Years</title>
            <description>lead age: greater than or equal to 6 years</description>
          </group>
        </group_list>
        <measure>
          <title>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Externalized Conductors to Electrical Dysfunction, by Year of Initial Implant</title>
          <description>Kaplan-Meier analysis of time from externalized conductors (EC) to electrical dysfunction, by year of initial implant. Count of cumulative lead anomaly events from time of detecting EC</description>
          <population>N at risk from detecting externalized conductors at each follow-up time point</population>
          <units>lead anomaly events</units>
          <param>Number</param>
          <units_analyzed>Implant Leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="67"/>
                <count group_id="O6" value="93"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="34"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="12"/>
                <count group_id="O11" value="15"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implant Leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="67"/>
                <count group_id="O6" value="93"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="34"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="12"/>
                <count group_id="O11" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>year 0 from detecting externalized conductor</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="67"/>
                    <count group_id="O6" value="93"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="34"/>
                    <count group_id="O9" value="12"/>
                    <count group_id="O10" value="12"/>
                    <count group_id="O11" value="15"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="67"/>
                    <count group_id="O6" value="93"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="34"/>
                    <count group_id="O9" value="12"/>
                    <count group_id="O10" value="12"/>
                    <count group_id="O11" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>year 1 from detecting externalized conductor</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="30"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="63"/>
                    <count group_id="O7" value="16"/>
                    <count group_id="O8" value="26"/>
                    <count group_id="O9" value="11"/>
                    <count group_id="O10" value="9"/>
                    <count group_id="O11" value="13"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="30"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="63"/>
                    <count group_id="O7" value="16"/>
                    <count group_id="O8" value="26"/>
                    <count group_id="O9" value="11"/>
                    <count group_id="O10" value="9"/>
                    <count group_id="O11" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="NA">no data available</measurement>
                    <measurement group_id="O3" value="NA">no data available</measurement>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>year 2 from detecting externalized conductor</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="27"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="8"/>
                    <count group_id="O8" value="22"/>
                    <count group_id="O9" value="5"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="9"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="27"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="8"/>
                    <count group_id="O8" value="22"/>
                    <count group_id="O9" value="5"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">no data available</measurement>
                    <measurement group_id="O2" value="NA">no data available</measurement>
                    <measurement group_id="O3" value="NA">no data available</measurement>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>year 3 from detecting externalized conductor</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="5"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="5"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="5"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="15"/>
                    <count group_id="O7" value="5"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="5"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">no data available</measurement>
                    <measurement group_id="O2" value="NA">no data available</measurement>
                    <measurement group_id="O3" value="NA">no data available</measurement>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="NA">no data available</measurement>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Other Visual Lead Anomaly to Electrical Dysfunction, by Year of Initial Implant</title>
        <description>Kaplan-Meier analysis of time from other visual lead anomaly to electrical dysfunction, by year of initial implant. Count of cumulative lead anomaly events from time of detecting other visual lead anomaly</description>
        <time_frame>This outcome is assessed from time of detecting other visual lead anomaly till the course of 3 years of follow-up</time_frame>
        <population>N at risk from detecting other visual lead anomaly</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads Lead Age: Less Than 4 Years</title>
            <description>lead age: less than 4 years</description>
          </group>
          <group group_id="O2">
            <title>Durata Leads Lead Age: 4 to Less Than 5 Years</title>
            <description>lead age: 4 to less than 5 years</description>
          </group>
          <group group_id="O3">
            <title>Durata Leads Lead Age: 5 Years or Greater</title>
            <description>lead age: 5 years or greater</description>
          </group>
          <group group_id="O4">
            <title>Riata Leads Lead Age: Less Than 6 Years</title>
            <description>lead age: less than 6 years</description>
          </group>
          <group group_id="O5">
            <title>Riata Leads Lead Age: 6-less Than 7 Years</title>
            <description>lead age: 6-less than 7 years</description>
          </group>
          <group group_id="O6">
            <title>Riata Leads Lead Age: 7 Years or Greater</title>
            <description>lead age: 7 years or greater</description>
          </group>
          <group group_id="O7">
            <title>Riata ST Lead Age: Less Than 5.5 Years</title>
            <description>lead age: less than 5.5 years</description>
          </group>
          <group group_id="O8">
            <title>Riata ST Leads Lead Age: Greater Than or Equal to 5.5 Years</title>
            <description>lead age: greater than or equal to 5.5 years</description>
          </group>
          <group group_id="O9">
            <title>QuickSite/QuickFlex Lead Age: Less Than 5 Years</title>
            <description>lead age: less than 5 years</description>
          </group>
          <group group_id="O10">
            <title>QuickSite/QuickFlex Leads Lead Age: 5 to Less Than 6 Years</title>
            <description>lead age: 5 to less than 6 years</description>
          </group>
          <group group_id="O11">
            <title>QuickSite/QuickFlex Leads Lead Age: Greater Than or Equal to 6 Years</title>
            <description>lead age: greater than or equal to 6 years</description>
          </group>
        </group_list>
        <measure>
          <title>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Other Visual Lead Anomaly to Electrical Dysfunction, by Year of Initial Implant</title>
          <description>Kaplan-Meier analysis of time from other visual lead anomaly to electrical dysfunction, by year of initial implant. Count of cumulative lead anomaly events from time of detecting other visual lead anomaly</description>
          <population>N at risk from detecting other visual lead anomaly</population>
          <units>lead anomaly events</units>
          <param>Number</param>
          <units_analyzed>Implant Leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="7"/>
                <count group_id="O9" value="2"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implant Leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="7"/>
                <count group_id="O9" value="2"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 years follow up from detecting other visual lead anomaly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="6"/>
                    <count group_id="O8" value="7"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="6"/>
                    <count group_id="O8" value="7"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 years follow up from detecting other visual lead anomaly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="5"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="7"/>
                    <count group_id="O7" value="5"/>
                    <count group_id="O8" value="5"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="2"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="5"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="7"/>
                    <count group_id="O7" value="5"/>
                    <count group_id="O8" value="5"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years follow up from detecting other visual lead anomaly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years follow up from detecting other visual lead anomaly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="2"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="2"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With an Adverse Event Through 30 Days Post-intervention for Lead (e.g. Extraction, Abandonment, Revision, Other).</title>
        <description>Number of participants with adverse events within 30 days associated with study lead related interventions for each lead group</description>
        <time_frame>within 30 days associated with study lead related interventions</time_frame>
        <population>Subject has at least one market released Riata, Riata ST, QuickSite/QuickFlex, or Durata lead implanted</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads</title>
            <description>Durata leads implanted between 2008-2010</description>
          </group>
          <group group_id="O2">
            <title>Riata Leads</title>
            <description>Riata leads implanted between 2002-2009</description>
          </group>
          <group group_id="O3">
            <title>Riata ST Leads</title>
            <description>Riata ST leads implanted between 2006-2009</description>
          </group>
          <group group_id="O4">
            <title>QuickSite/QuickFlex Leads</title>
            <description>Quicksite or QuickFlex leads implanted between 2006-2010</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With an Adverse Event Through 30 Days Post-intervention for Lead (e.g. Extraction, Abandonment, Revision, Other).</title>
          <description>Number of participants with adverse events within 30 days associated with study lead related interventions for each lead group</description>
          <population>Subject has at least one market released Riata, Riata ST, QuickSite/QuickFlex, or Durata lead implanted</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="982"/>
                <count group_id="O2" value="670"/>
                <count group_id="O3" value="458"/>
                <count group_id="O4" value="737"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Lead dislodgement or migration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>lead insulation damage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>phrenic nerve/diaphragmatic stimulation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Externalized Conductors to Clinical Intervention, by Year of Initial Implant</title>
        <description>time from externalized conductors to clinical intervention for all lead subgroups.</description>
        <time_frame>This outcome is assessed from time of detection of externalized conductor to 3 years follow-up</time_frame>
        <population>N at risk from time of externalized conductors at each follow-up period</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads Lead Age: Less Than 4 Years</title>
            <description>lead age: less than 4 years</description>
          </group>
          <group group_id="O2">
            <title>Durata Leads Lead Age: 4 to Less Than 5 Years</title>
            <description>lead age: 4 to less than 5 years</description>
          </group>
          <group group_id="O3">
            <title>Durata Leads Lead Age: 5 Years or Greater</title>
            <description>lead age: 5 years or greater</description>
          </group>
          <group group_id="O4">
            <title>Riata Leads Lead Age: Less Than 6 Years</title>
            <description>lead age: less than 6 years</description>
          </group>
          <group group_id="O5">
            <title>Riata Leads Lead Age: 6-less Than 7 Years</title>
            <description>lead age: 6-less than 7 years</description>
          </group>
          <group group_id="O6">
            <title>Riata Leads Lead Age: 7 Years or Greater</title>
            <description>lead age: 7 years or greater</description>
          </group>
          <group group_id="O7">
            <title>Riata ST Lead Age: Less Than 5.5 Years</title>
            <description>lead age: less than 5.5 years</description>
          </group>
          <group group_id="O8">
            <title>Riata ST Leads Lead Age: Greater Than or Equal to 5.5 Years</title>
            <description>lead age: greater than or equal to 5.5 years</description>
          </group>
          <group group_id="O9">
            <title>QuickSite/QuickFlex Lead Age: Less Than 5 Years</title>
            <description>lead age: less than 5 years</description>
          </group>
          <group group_id="O10">
            <title>QuickSite/QuickFlex Leads Lead Age: 5 to Less Than 6 Years</title>
            <description>lead age: 5 to less than 6 years</description>
          </group>
          <group group_id="O11">
            <title>QuickSite/QuickFlex Leads Lead Age: Greater Than or Equal to 6 Years</title>
            <description>lead age: greater than or equal to 6 years</description>
          </group>
        </group_list>
        <measure>
          <title>Estimation of Cumulative Lead Anomaly Events From Time of Detecting Externalized Conductors to Clinical Intervention, by Year of Initial Implant</title>
          <description>time from externalized conductors to clinical intervention for all lead subgroups.</description>
          <population>N at risk from time of externalized conductors at each follow-up period</population>
          <units>lead anomaly events</units>
          <param>Number</param>
          <units_analyzed>Implant Leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="67"/>
                <count group_id="O6" value="93"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="34"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="12"/>
                <count group_id="O11" value="15"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implant Leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="42"/>
                <count group_id="O5" value="67"/>
                <count group_id="O6" value="93"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="34"/>
                <count group_id="O9" value="12"/>
                <count group_id="O10" value="12"/>
                <count group_id="O11" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 years from detecting EC</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="67"/>
                    <count group_id="O6" value="93"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="34"/>
                    <count group_id="O9" value="12"/>
                    <count group_id="O10" value="12"/>
                    <count group_id="O11" value="15"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="67"/>
                    <count group_id="O6" value="93"/>
                    <count group_id="O7" value="23"/>
                    <count group_id="O8" value="34"/>
                    <count group_id="O9" value="12"/>
                    <count group_id="O10" value="12"/>
                    <count group_id="O11" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year from detecting EC</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="63"/>
                    <count group_id="O7" value="16"/>
                    <count group_id="O8" value="26"/>
                    <count group_id="O9" value="11"/>
                    <count group_id="O10" value="9"/>
                    <count group_id="O11" value="13"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="31"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="63"/>
                    <count group_id="O7" value="16"/>
                    <count group_id="O8" value="26"/>
                    <count group_id="O9" value="11"/>
                    <count group_id="O10" value="9"/>
                    <count group_id="O11" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years from detecting EC</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="27"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="8"/>
                    <count group_id="O8" value="22"/>
                    <count group_id="O9" value="5"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="9"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="19"/>
                    <count group_id="O5" value="27"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="8"/>
                    <count group_id="O8" value="22"/>
                    <count group_id="O9" value="5"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">no data available</measurement>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="15"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="4"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years from detecting EC</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="8"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="5"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="5"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="12"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="8"/>
                    <count group_id="O8" value="8"/>
                    <count group_id="O9" value="5"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">no data available</measurement>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="18"/>
                    <measurement group_id="O7" value="6"/>
                    <measurement group_id="O8" value="6"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimation of Lead Anomaly Events From Time of Other Visual Lead Anomalies by Each Subcategory to Clinical Intervention, by Year of Initial Implant</title>
        <description>Kaplan-Meier analysis of time from visual lead anomalies for all lead and lead age subcategories to clinical intervention</description>
        <time_frame>This outcome is assessed from time of detection of other visual lead anomaly until 3 years of follow-up</time_frame>
        <population>N at risk from time of detecting visual lead anomaly at each follow-up period</population>
        <group_list>
          <group group_id="O1">
            <title>Durata Leads Lead Age: Less Than 4 Years</title>
            <description>lead age: less than 4 years</description>
          </group>
          <group group_id="O2">
            <title>Durata Leads Lead Age: 4 to Less Than 5 Years</title>
            <description>lead age: 4 to less than 5 years</description>
          </group>
          <group group_id="O3">
            <title>Durata Leads Lead Age: 5 Years or Greater</title>
            <description>lead age: 5 years or greater</description>
          </group>
          <group group_id="O4">
            <title>Riata Leads Lead Age: Less Than 6 Years</title>
            <description>lead age: less than 6 years</description>
          </group>
          <group group_id="O5">
            <title>Riata Leads Lead Age: 6-less Than 7 Years</title>
            <description>lead age: 6-less than 7 years</description>
          </group>
          <group group_id="O6">
            <title>Riata Leads Lead Age: 7 Years or Greater</title>
            <description>lead age: 7 years or greater</description>
          </group>
          <group group_id="O7">
            <title>Riata ST Lead Age: Less Than 5.5 Years</title>
            <description>lead age: less than 5.5 years</description>
          </group>
          <group group_id="O8">
            <title>Riata ST Leads Lead Age: Greater Than or Equal to 5.5 Years</title>
            <description>lead age: greater than or equal to 5.5 years</description>
          </group>
          <group group_id="O9">
            <title>QuickSite/QuickFlex Lead Age: Less Than 5 Years</title>
            <description>lead age: less than 5 years</description>
          </group>
          <group group_id="O10">
            <title>QuickSite/QuickFlex Leads Lead Age: 5 to Less Than 6 Years</title>
            <description>lead age: 5 to less than 6 years</description>
          </group>
          <group group_id="O11">
            <title>QuickSite/QuickFlex Leads Lead Age: Greater Than or Equal to 6 Years</title>
            <description>lead age: greater than or equal to 6 years</description>
          </group>
        </group_list>
        <measure>
          <title>Estimation of Lead Anomaly Events From Time of Other Visual Lead Anomalies by Each Subcategory to Clinical Intervention, by Year of Initial Implant</title>
          <description>Kaplan-Meier analysis of time from visual lead anomalies for all lead and lead age subcategories to clinical intervention</description>
          <population>N at risk from time of detecting visual lead anomaly at each follow-up period</population>
          <units>lead anomaly events</units>
          <param>Number</param>
          <units_analyzed>Implant Leads</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="7"/>
                <count group_id="O9" value="2"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Implant Leads</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="6"/>
                <count group_id="O8" value="7"/>
                <count group_id="O9" value="2"/>
                <count group_id="O10" value="3"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 years from detection other visual lead anomaly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="6"/>
                    <count group_id="O8" value="7"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="6"/>
                    <count group_id="O8" value="7"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 years from detection other visual lead anomaly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="5"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="7"/>
                    <count group_id="O7" value="5"/>
                    <count group_id="O8" value="5"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="2"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="5"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="7"/>
                    <count group_id="O7" value="5"/>
                    <count group_id="O8" value="5"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 years from detection other visual lead anomaly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="6"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="3"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 years from detection other visual lead anomaly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="2"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Implant Leads</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="1"/>
                    <count group_id="O6" value="2"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison of Number of Patients With Externalized Conductors to Number of Patients Without Externalized Conductors (EC)</title>
        <description>Comparison of patients with EC to those without EC: lead size effect on number of patients with or without EC (7F and 8F are lead sizes, F = French). Riata leads have 8F diameter and Riata ST leads have 7F diameter. The Riata/Riata ST families of leads were used for this comparison only to determine whether the difference in lead size (with the silicon material and other lead design factors controlled for) had an effect on externalization of conductors.</description>
        <time_frame>This outcome is assessed from enrollment till the course of 3 years of follow-up</time_frame>
        <population>Patients with Riata or Riata ST leads.</population>
        <group_list>
          <group group_id="O1">
            <title>With Externalized Conductors (EC)</title>
            <description>EC identified</description>
          </group>
          <group group_id="O2">
            <title>Without Externalized Conductors (EC)</title>
            <description>No EC identified</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Number of Patients With Externalized Conductors to Number of Patients Without Externalized Conductors (EC)</title>
          <description>Comparison of patients with EC to those without EC: lead size effect on number of patients with or without EC (7F and 8F are lead sizes, F = French). Riata leads have 8F diameter and Riata ST leads have 7F diameter. The Riata/Riata ST families of leads were used for this comparison only to determine whether the difference in lead size (with the silicon material and other lead design factors controlled for) had an effect on externalization of conductors.</description>
          <population>Patients with Riata or Riata ST leads.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="261"/>
                <count group_id="O2" value="851"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7F lead size (Riata ST)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="395"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8F lead size (Riata)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="204"/>
                    <measurement group_id="O2" value="456"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison of Patients With Electrical Dysfunction to Those Without Electrical Dysfunction (ED).</title>
        <description>Comparison of patients with ED to those without ED: subject age effect on ED</description>
        <time_frame>This outcome is assessed from enrollment till the course of 3 years of follow-up</time_frame>
        <population>Patients implanted with SJM Riata, Riata ST, Durata, or QuickSite/QuickFlex leads. Leads were combined for this analysis to compare patient groups with and without electrical dysfunction based on age (irrespective of lead implant type)</population>
        <group_list>
          <group group_id="O1">
            <title>With Electrical Dysfunction (ED)</title>
            <description>ED identified</description>
          </group>
          <group group_id="O2">
            <title>Without Electrical Dysfunction (ED)</title>
            <description>No ED identified</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Patients With Electrical Dysfunction to Those Without Electrical Dysfunction (ED).</title>
          <description>Comparison of patients with ED to those without ED: subject age effect on ED</description>
          <population>Patients implanted with SJM Riata, Riata ST, Durata, or QuickSite/QuickFlex leads. Leads were combined for this analysis to compare patient groups with and without electrical dysfunction based on age (irrespective of lead implant type)</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="68"/>
                <count group_id="O2" value="2148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.8" spread="13.4"/>
                    <measurement group_id="O2" value="67.2" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From enrollment to 3 years of follow-up period</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Durata Leads</title>
          <description>Subjects implanted with SJM Durata leads</description>
        </group>
        <group group_id="E2">
          <title>Riata Leads</title>
          <description>Subjects implanted with Riata leads</description>
        </group>
        <group group_id="E3">
          <title>Riata ST Leads</title>
          <description>Subjects implanted with Riata ST leads</description>
        </group>
        <group group_id="E4">
          <title>QuickSite/QuickFlex Leads</title>
          <description>Subjects implanted with QuickSite/QuickFlex leads</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="130" subjects_at_risk="982"/>
                <counts group_id="E2" subjects_affected="111" subjects_at_risk="670"/>
                <counts group_id="E3" subjects_affected="64" subjects_at_risk="458"/>
                <counts group_id="E4" subjects_affected="135" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="982"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="670"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="458"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="737"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Abnormal high voltage lead impredance</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="982"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="670"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Abnormal Pacing Impedance</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="982"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Decline in R Wave Sensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Elevated pacing thresholds</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="670"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="458"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Externalized Conductor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Lead dislodgement or migration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>lead fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="982"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>lead insulation damage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="458"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>lead noise</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="982"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="670"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>oversensing</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="982"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="670"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>phrenic nerve/diaphragmatic stimulation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>shock due to AF with RVR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>undersensing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="982"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="670"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="458"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="737"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Abnormal High Voltage Lead Impedance</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="982"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Abnormal Pacing Impedance</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Decrease R Wave</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Elevated pacing thresholds</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="982"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="670"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="458"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Lead Insulation Damage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Lead Noise</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Loss of Capture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Loss of Sensing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Other Visual Lead Anomalies</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Oversensing</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="982"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="670"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Oversensing Resulting in Therapy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Pectoral Stimulation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Phrenic Nerve/Diaphragmatic Stimulation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Therapy for Non-Ventricular Rhythm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="982"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="670"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
              <event>
                <sub_title>Undersensing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="982"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="670"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="458"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="737"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The sponsor can review results communications prior to public release and embargo communications regarding trial results for 12 months from study completion date to allow time for multi-center study publication. After this period, the PI shall submit to sponsor for review a copy of any proposed manuscript at least 30 days prior to the estimated date of submission for publication. Sponsor may require delay of publication not to exceed 60 days for the purpose of filing patent applications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Grant Kim, Program Director - Traditional Cardiac Rhythm Management</name_or_title>
      <organization>Abbott</organization>
      <phone>818-493-3147</phone>
      <email>grant.kim1@abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

